LungBlog

Katherine Wilson was young and spirited, living her life every day as if it would be her last. She pursued higher education and traveled. She celebrated often with family and friends. Unfortunately, a lung cancer diagnosis ended Katherine’s life much too quickly at the age of 27 in 2005.

People who smoke but consume three or more servings of fruit and vegetables and regularly drink green or black tea may be keeping lung cancer at bay, new research suggests.

Potential advances in the treatment of lung cancer, the leading cause of cancer deaths in the United States, will be a major focus at a key meeting of oncology specialists starting on Friday.

A common genetic disorder that has previously been linked to lung disease may also put its carriers at a 70%-100% increased risk of lung cancer, according to an article released on May 26, 2008 in the Archives of Internal Medicine, one of the JAMA/Archives journals

Betacarotene has been the subject of controversy because of its failure to reduce the incidence of lung cancer in smokers. In fact, betacarotene when taken alone without vitamin C and E was shown to increase the liability to develop lung cancer. Conversely, when betacarotene was taken with vitamin C and E its influence was equivocal. It was recommended that those people who take betacarotene, which does have a beneficial effect on other tissues, should also take adequate vitamin C and E.

Three studies to be reported at the American Society of Clinical Oncology (ASCO) Annual Meeting used Thomson Reuters Cancer Profiler tools to gain insights into the adverse effects of treatment for head and neck cancers and lung cancer.

By wrapping tumor-suppressing genes in tiny balls of fat, Roth and colleagues hope to be able to treat more invasive cancers. While p53 nanoparticles are still in preclinical development, those that deliver another tumor-suppressor called FUS1 are in a phase I clinical trial for non-small cell lung cancer. Through 19 patients, the dose escalation study has yet to encounter significant side effects.

ImClone Systems Inc. (IMCL), Novartis AG (NVS), Eli Lilly & Co. (LLY) and Genentech Inc. (DNA) are among the drug companies set to showcase their efforts in the battle against cancer at a large medical meeting beginning Friday.The American Society of Clinical Oncology is holding its five-day annual meeting in Chicago, where more than 25,000 cancer doctors are expected to hear the latest in cancer research. As usual, some of the most eagerly awaited data are for drugs that treat the top killers – cancers of the lung, breast and colon.

The Kate MacIntyre Foundation is proud to announce the launch of its website katemacintryefoundation.org as it seeks to increase the awareness of lung cancer in non smokers. With the reach of this site, the foundation hopes to support lung cancer patient advocacy, encourage clinical research trials, mentor young professional women interested in a health care profession and raise money for this important efforts.

Carriers of one of the most common genetic disorders in the U.S. may have a 70 to 100 percent increased chance of developing lung cancer, new research reveals.According to a recent study, alpha1-antitrypsin deficiency (a1ATD), a genetic mutation previously linked to lung disease, affects at least 10 million Americans. Researchers found a strong association between this under-diagnosed disorder and lung cancer.